Abstract:BACKGROUND:Combretastatin A-4 (CA-4), which is an excellent antineoplastic agent, was isolated from Combretum caffrum. To date, structural modification studies of CA-4 have focused predominantly on the construction of new therapeutic agents for drug discovery. As a part of our ongoing work towards the modification of natural products, we have focused on the 3'-O-substituent groups in the B-ring of CA-4 under the hypothesis that these novel derivatives will possess good bioactivities and behave as effective antiproliferative pro-drugs.RESULTS:A series of novel CA-4 derivatives, which contained a 3'-O-substituted carbonic ether moiety, were synthesized and evaluated for their antitumor activities against four tumor cell lines, including MDA-MB-231, MCF-7, K562 and A549 cells. These derivatives exhibited clear antitumor activities, and CA-4E, in particular, showed the highest bioactivity of all of the derivatives tested against all four tumor cell lines, with IC50 values in the range of 1 to 180 nM. Based on its high bioactivity, CA-4E was subsequently selected to investigate the antitumor mechanism of these synthetic compounds. The cell cycle results demonstrated that CA-4E induced time- and dose-dependent G2/M arrest in a similar manner to CA-4, although its effect was more powerful than that of CA-4, and the apoptosis data showed that CA-4E induced cellular apoptosis in a dose-dependent manner.CONCLUSIONS:The newly synthesized CA-4 derivatives exhibited good antitumor activities in vitro, with CA-4E, in particular, showing the highest bioactivity of all of the compounds tested. Furthermore, CA-4E induced time- and dose-dependent G2/M arrest and cellular apoptosis in a dose-dependent manner. Taken together, these results suggest that CA-4E should be subjected to further investigation as a potential anticancer drug candidate.

Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents.

Design and Synthesis of Novel Spin-Labeled Camptothecin Derivatives As Potent Cytotoxic Agents.

Synthesis of Novel Spin-Labeled Derivatives of 5-FU As Potential Antineoplastic Agents

Synthesis of Novel Spin-Labelled Combretastatin A-4 Derivatives As Potential Antineoplastic Agents

Synthesis, biological evaluation and mechanism study of a class of cyclic combretastatin A-4 analogues as novel antitumour agents

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin As Potent Antitumor Agents

Synthesis of Novel Spin-Labeled Podophyllotoxin Derivatives As Potential Antineoplastic Agents: Part XXV

Novel Combretastatin A-4 Analogs—Design, Synthesis, and Antiproliferative and Anti-Tubulin Activity

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis and Biological Evaluation of Combretastatin A-4 Derivatives Containing a 3'-O-substituted Carbonic Ether Moiety As Potential Antitumor Agents.

Synthesis,characterization and Biological Activities of Nitrogen-Containing Combretastatin A-4 Derivatives

Synthesis and biological evaluation of cyclic derivatives of combretastatin A-4 containing group 14 elements

Design, Synthesis, Biological Evaluation and Cocrystal Structures with Tubulin of Chiral Β-Lactam Bridged Combretastatin A-4 Analogues As Potent Antitumor Agents.

First Synthesis of Novel Spin-Labeled Derivatives of Camptothecin As Potential Antineoplastic Agents

Design and Synthesis of Cyclopropylamide Analogues of Combretastatin-A4 As Novel Microtubule-Stabilizing Agents

Synthesis and Antitumor Activity of Biotinylated Camptothecin Derivatives As Potent Cytotoxic Agents.

Design, Synthesis, And Biological Evaluation Of Hydantoin Bridged Analogues Of Combretastatin A-4 As Potential Anticancer Agents

Synthesis and In-Vitro Cytotoxicity of (E)-N,2,3-triarylacrylamide Derivatives As Analogs of Combretastatin A-4

Synthesis and Antitumor Activity of a Series of Novel N-aryl-5-(2,2,2-trifluoroethoxy)-1,5-dihydro-2H-pyrrol-2-ones Derivatives

Discovery of a potent microtubule-targeting agent: Synthesis and biological evaluation of water-soluble amino acid prodrug of combretastatin A-4 derivatives.